period increased by 2.1% ( table 1 ) . Distinguishing between the various thyroid hormone preparations, the number of persons using only T 4 increased by 53%, those using the combination of T 4 + T 3 increased by 67%, and those using T 3 only increased by 36%. Among the persons using thyroid hormones, the proportion of only T 4 users gradually but consistently decreased from 99.05% in 2005 to 98.98% in 2011. An opposite trend was observed in the T 4 + T 3 users, which slowly but steadily increased from 0.82% in 2005 to 0.90% in 2011. The proportion of only T 3 users did not show a specific trend -it was 0.13% in 2005 and 0.12% in 2011. The assembled data also allowed to analyse whether prescriptions were made by general physicians (GPs) or specialists ( table 2 ) Two conclusions can be drawn. The number of persons using thyroid hormone medication increased substantially in the period 2005-2011. And the proportion of thyroid hormone medication prescribed by GPs steadily increased in this period, whereas the proportion prescribed by specialists decreased. How can these remarkable trends be explained? We offer a few causal mechanisms.
First, the growth of the Dutch population size between 2005 and 2011 will have contributed to the increased number of persons taking thyroid hormone. However, this provides only a partial explanation because the relative increase of thyroid hormone users exceeds by far the relative increase of population size.
Second, the composition of the Dutch population is changing with a strong increase of the ageing population. As the incidence of Hashimoto's hypothyroidism increases with advancing age, a greying de Jong /Baljet Eur Thyroid J 2012; 1:135-136 population will increase the use of thyroid hormones. Nevertheless, this cannot be the whole explanation because the effect of the ageing population is just three times greater than the effect of the general population growth.
Third, the Dutch College of General Practitioners (Nederlands Huisartsen Genootschap) published in 2006 guidelines for the diagnosis and treatment of thyroid function disorders [1, 2] . At the implementation of the guidelines, specific attention was drawn to the condition of subclinical hypothyroidism. It is plausible that the guidelines to a large extent have contributed to the increased use of thyroid hormone, also explaining the shift in prescription behaviour away from the specialists towards the GPs. In further support of this explanation is the introduction of specific software used by laboratories serving GPs. The GP can cross the box 'tiredness', which automatically results in a few laboratory tests including TSH. Many GPs express their amazement when the assay indicates hypothyroidism.
However, we would like to suggest a fourth explanation, which we call the Google hypothesis. Many subjects have vague non-specific complaints, and are inclined to look on the internet what might be wrong. In doing so, it is not unusual to arrive at websites related to thyroid diseases. In the Netherlands, the websites of the thyroid patient associations (Thyroid Foundation Netherlands, Dutch Association of Graves' Patients, Hypo but not Happy) are consulted by more than 10,000 individual visitors per week. It might well be that these visitors subsequently consult their GP with the specific request to determine thyroid function. In this respect it is noteworthy to mention that the relative increase in users of the combination therapy of T 4 + T 3 (as recommended by the Hypo but not Happy group in particular cases) is greater than the relative increase of only T 4 users. The combination therapy appears to be described increasingly by GPs. Indeed, the GP guidelines in a footnote mention the possibility to use this treatment modality.
We do not know if our explanations account for the whole increase of thyroid hormone use, nor do we know whether this definite trend in increasing use of thyroid hormones will go on or stop within a few years. 
